1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
2.2 Computed Tomography (CT) Systems Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10
3 Computed Tomography (CT) Systems Market, North America 11
3.1 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2008-2022 11
3.2 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2008-2015 13
3.3 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2015-2022 15
3.4 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022 17
3.5 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2015 18
3.6 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2015-2022 20
3.7 Computed Tomography (CT) Systems Market, North America, Company Share by Revenue ($m), 2015 22
4 Computed Tomography (CT) Systems Market, Canada 24
4.1 Computed Tomography (CT) Systems Market, Canada, Revenue ($m), 2008-2015 24
4.2 Computed Tomography (CT) Systems Market, Canada, Revenue ($m), 2015-2022 26
4.3 Computed Tomography (CT) Systems Market, Canada, Volume (Units), 2008-2015 28
4.4 Computed Tomography (CT) Systems Market, Canada, Volume (Units), 2015-2022 30
4.5 Computed Tomography (CT) Systems Market, Canada, Average Price ($), 2008-2022 32
4.6 Computed Tomography (CT) Systems Market, Canada, Distribution Share by Revenue ($m), 2014-2015 34
4.7 Computed Tomography (CT) Systems Market, Canada, Company Share by Revenue ($m), 2015 35
5 Computed Tomography (CT) Systems Market, Mexico 36
5.1 Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), 2008-2015 36
5.2 Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), 2015-2022 38
5.3 Computed Tomography (CT) Systems Market, Mexico, Volume (Units), 2008-2015 40
5.4 Computed Tomography (CT) Systems Market, Mexico, Volume (Units), 2015-2022 42
5.5 Computed Tomography (CT) Systems Market, Mexico, Average Price ($), 2008-2022 44
5.6 Computed Tomography (CT) Systems Market, Mexico, Distribution Share by Revenue ($m), 2014-2015 46
5.7 Computed Tomography (CT) Systems Market, Mexico, Company Share by Revenue ($m), 2015 47
6 Computed Tomography (CT) Systems Market, United States 49
6.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2008-2015 49
6.2 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2015-2022 51
6.3 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2008-2015 53
6.4 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2015-2022 55
6.5 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2008-2022 57
6.6 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015 59
6.7 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2015 60
7 Overview of Key Companies in North America Computed Tomography (CT) Systems Market 62
7.1 Siemens Limited 62
7.1.1 Company Overview 62
7.2 GE Healthcare Ltd 62
7.2.1 Company Overview 62
7.3 Toshiba Medical Systems Corporation 62
7.3.1 Company Overview 62
7.4 Philips Healthcare 63
7.4.1 Company Overview 63
8 Computed Tomography (CT) Systems Market Pipeline Products 64
9 Recent Developments 66
9.1 Corporate Communications 66
9.1.1 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index 66
9.1.2 Dec 12, 2016: VIDA Diagnostics names new COO 66
9.1.3 Nov 22, 2016: USC Roski Eye Institute conducted patient trials for breakthrough refractory glaucoma treatment 67
9.1.4 Nov 22, 2016: Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma Gene Expression Classifier in 2017 68
9.1.5 Oct 24, 2016: Analogic Announces Leadership Transition 69
9.1.6 Sep 27, 2016: Camargo Pharmaceutical Services Adds to Medical Device Expertise 70
9.1.7 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories 71
9.1.8 Sep 08, 2016: iCAD Announces Management Transition 71
9.1.9 Sep 06, 2016: GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler in COPD at ERS International Congress 72
9.1.10 Sep 01, 2016: NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China 74
9.1.11 Aug 31, 2016: Bruce Elder Named CEO of MedQuest 75
9.1.12 Aug 10, 2016: Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts 76
9.1.13 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions 76
9.1.14 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market 77
9.1.15 May 25, 2016: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member 77
9.1.16 May 11, 2016: Regeneron and Sanofi Genzyme to Present Additional Data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society International Conference 78
9.1.17 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA 79
9.1.18 Apr 21, 2016: RefleXion Medical Strengthens Management Team to Bring Biology-Guided Radiotherapy Into the Clinic 81
9.1.19 Feb 25, 2016: Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation 82
9.1.20 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer 84
9.1.21 Feb 17, 2016: Alliance HealthCare Services Announces Rhonda Longmore-Grund to Assume Chief Financial Officer Role as Part of Planned Transition 84
9.1.22 Feb 08, 2016: Timothy Damadian Named President and CEO of FONAR 85
9.1.23 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic’s Board 86
9.2 Financial Announcements 87
9.2.1 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 87
9.2.2 Dec 06, 2016: Analogic Announces Results for the First Quarter ended October 31, 2016 and Declares Quarterly Cash Dividend 88
9.2.3 Nov 29, 2016: Imaging Dynamics Q3 net loss increases 89
9.2.4 Nov 09, 2016: FONAR Announces 1st Quarter Financial Results For Fiscal 2017 90
9.2.5 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results 91
9.2.6 Nov 03, 2016: Alliance HealthCare Services Reports Results for the Third Quarter Ended September 30, 2016 93
9.2.7 Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results 94
9.2.8 Oct 27, 2016: Stryker reports third quarter 2016 results 96
9.2.9 Oct 27, 2016: Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance 98
9.2.10 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 99
9.2.11 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend 100
9.2.12 Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings 102
9.2.13 Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results 103
9.2.14 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results 105
9.2.15 Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016 106
9.2.16 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results 108
9.2.17 Jul 25, 2016: Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA 110
9.2.18 Jul 25, 2016: VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate 112
9.2.19 Jul 21, 2016: Stryker reports second quarter 2016 results 113
9.2.20 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 114
9.2.21 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend 116
9.2.22 May 10, 2016: FONAR Announces 3rd Quarter and Nine Months Financial Results for Fiscal 2016 117
9.2.23 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results 119
9.2.24 May 05, 2016: Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2016 121
9.2.25 May 03, 2016: ICAD Reports First Quarter 2016 Financial Results 122
9.2.26 Mar 10, 2016: Alliance HealthCare Services Reports Fourth Quarter & Full Year 2015 Results 124
9.2.27 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend 126
9.2.28 Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results 128
9.2.29 Feb 09, 2016: FONAR Announces Fiscal 2016 2nd Quarter and Six Months Financial Results 130
9.3 Government and Public Interest 131
9.3.1 Jun 05, 2016: LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer 131
9.3.2 May 23, 2016: Teijin Pharma’s Feburic (Febuxostat) Approved as Indication for Cancer Chemotherapy-Induced Hyperuricemia 133
9.3.3 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress 135
9.3.4 Apr 25, 2016: GlycoMimetics Data on GMI-1271 Treatment of Acetaminophen-Triggered Liver Toxicity to Be Presented at "Digestive Disease Week" Conference 137
9.3.5 Apr 13, 2016: Bio Products Laboratory Announces FDA Submission of Biologics License Supplement for Gammaplex 10% 138
9.3.6 Mar 01, 2016: Nordic Nanovector: Late-Breaking Abstract on Betalutin Phase 1/2 Study Accepted for Presentation at American Association for Cancer Research Annual Meeting 2016 139
9.3.7 Jan 28, 2016: European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV 141
9.4 Legal And Regulatory 143
9.4.1 Aug 15, 2016: Med Center Health Facilities Earn ACR Lung Cancer Screening Center Designation 143
9.5 Other Significant Developments 143
9.5.1 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program 143
9.5.2 Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography 144
9.5.3 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies 145
9.5.4 May 12, 2016: IMRIS, Deerfield Imaging Announces New Department - Office of the Customer 146
9.5.5 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead 146
9.5.6 Mar 22, 2016: The University of Tennessee College of Medicine Launches the World’s First Mobile Stroke Unit with Advanced CT Imaging Capabilities Including CT Angiography Imaging for the Brain and Blood Vessels 148
9.6 Product News 149
9.6.1 Dec 19, 2016: Algorithm provides an extra level of assurance during spine surgery 149
9.6.2 Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis 151
9.6.3 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress 151
9.6.4 Sep 06, 2016: Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa Hospital 152
9.6.5 Jun 08, 2016: NICE draft recommendation on the use of aflibercept (EYLEA) for management of branch retinal vein occlusion goes against Royal College of Ophthalmologists’ guidance 153
9.6.6 Apr 26, 2016: Philips receives FDA 510(k) clearance of CT imaging solutions for lung cancer screening to help hospitals of all sizes drive earlier detection and improve patient care decisions 155
9.7 Strategy And Business Planning 156
9.7.1 Nov 09, 2016: Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia (ferric citrate) 156
9.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 157
9.7.3 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR 158
10 Appendix 160
10.1 Research Methodology 161
10.1.1 Coverage 161
10.1.2 Secondary Research 161
10.1.3 Primary Research 162
10.1.4 Market Modeling and Forecasting 163
10.1.5 Company Share Analysis 164
10.1.6 Distribution Share Analysis 165
10.1.7 Benchmarking 165
10.2 GlobalData Consulting 165
10.3 Contact Us 166
10.4 Disclaimer 166

1.1 List of Tables
Table 1: Computed Tomography (CT) Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 12
Table 2: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 14
Table 3: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 16
Table 4: Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022 17
Table 5: Computed Tomography (CT) Systems Market, North America, Volume (Units), Historic, 2008-2015 19
Table 6: Computed Tomography (CT) Systems Market, North America, Volume (Units), Forecast, 2015-2022 21
Table 7: Computed Tomography (CT) Systems Market, North America, Company Share by Revenue ($m), USD Constant, 2015 23
Table 8: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 25
Table 9: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 27
Table 10: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Historic, 2008-2015 29
Table 11: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Forecast, 2015-2022 31
Table 12: Computed Tomography (CT) Systems Market, Canada, Average Price ($), Historic, 2008-2015 32
Table 13: Computed Tomography (CT) Systems Market, Canada, Average Price ($), Forecast, 2015-2022 33
Table 14: Computed Tomography (CT) Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 34
Table 15: Computed Tomography (CT) Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 35
Table 16: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 37
Table 17: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 39
Table 18: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Historic, 2008-2015 41
Table 19: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Forecast, 2015-2022 43
Table 20: Computed Tomography (CT) Systems Market, Mexico, Average Price ($), Historic, 2008-2015 44
Table 21: Computed Tomography (CT) Systems Market, Mexico, Average Price ($), Forecast, 2015-2022 45
Table 22: Computed Tomography (CT) Systems Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015 46
Table 23: Computed Tomography (CT) Systems Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015 48
Table 24: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 50
Table 25: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 52
Table 26: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 54
Table 27: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 56
Table 28: Computed Tomography (CT) Systems Market, United States, Average Price ($), Historic, 2008-2015 57
Table 29: Computed Tomography (CT) Systems Market, United States, Average Price ($), Forecast, 2015-2022 58
Table 30: Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015 59
Table 31: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2015 61
Table 32: Computed Tomography (CT) Systems Market Pipeline Products 64

1.2 List of Figures
Figure 1: Computed Tomography (CT) Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022 11
Figure 2: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015 13
Figure 3: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022 15
Figure 4: Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022 17
Figure 5: Computed Tomography (CT) Systems Market, North America, Volume (Units), Historic, 2008-2015 18
Figure 6: Computed Tomography (CT) Systems Market, North America, Volume (Units), Forecast, 2015-2022 20
Figure 7: Computed Tomography (CT) Systems Market, North America, Company Share (%) 2015 22
Figure 8: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 24
Figure 9: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 26
Figure 10: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Historic, 2008-2015 28
Figure 11: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Forecast, 2015-2022 30
Figure 12: Computed Tomography (CT) Systems Market, Canada, Company Share (%) 2015 35
Figure 13: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015 36
Figure 14: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022 38
Figure 15: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Historic, 2008-2015 40
Figure 16: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Forecast, 2015-2022 42
Figure 17: Computed Tomography (CT) Systems Market, Mexico, Company Share (%) 2015 47
Figure 18: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015 49
Figure 19: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022 51
Figure 20: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015 53
Figure 21: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022 55
Figure 22: Computed Tomography (CT) Systems Market, United States, Company Share (%) 2015 60